You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 66 No. 3, SEPTEMBER 1940 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

PANCREATIC SECRETION IN MAN AFTER STIMULATION WITH SECRETIN AND ACETYLBETAMETHYLCHOLINE CHLORIDE

A COMPARATIVE STUDY

MANDRED W. COMFORT, M.D.; ARNOLD E. OSTERBERG, Ph.D.

Arch Intern Med. 1940;66(3):688-706.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Secretory activity of the pancreas may be stimulated by either a humoral (secretin) or a neural (vagal) mechanism. The amount and type of secretion produced by the two mechanisms has been shown to differ widely in animals. Stimulation with secretin produces a large volume of pancreatic juice rich in bicarbonate and poor in enzymes, whereas vagal stimulation produces a scant flow of juice poor in bicarbonate and rich in enzymes. Mellanby1 hypothesized that the content of enzymes in the pancreatic juice is determined by action of the vagus nerves, whereas the concentration of the bicarbonate solution in which these enzymes are contained is determined by the action of secretin. In a clinical study of pancreatic function, the response of the pancreas to both types of stimulants should be determined in order to obtain a complete picture.

In man, the effect of intravenous injection of purified secretin was first studied, . . . [Full Text PDF of this Article]


Author Affiliations

ROCHESTER, MINN.

From the Division of Medicine (Dr. Comfort) and the Division of Biochemistry (Dr. Osterberg), the Mayo Clinic.


Footnotes

Read at a meeting of the Central Society for Clinical Research, Chicago, Nov. 4, 1939.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1940 American Medical Association. All Rights Reserved.